YU38503A - Postupci i vakcine za pružanje zaštite in ovo protiv ćurećeg rinotraheitisa - Google Patents
Postupci i vakcine za pružanje zaštite in ovo protiv ćurećeg rinotraheitisaInfo
- Publication number
- YU38503A YU38503A YU38503A YUP38503A YU38503A YU 38503 A YU38503 A YU 38503A YU 38503 A YU38503 A YU 38503A YU P38503 A YUP38503 A YU P38503A YU 38503 A YU38503 A YU 38503A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- methods
- vaccines
- turkey rhinotracheitis
- providing
- protection against
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
- C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Postupci i preparati za zaštitu peradi (npr. ćurke i/ili pilići) od virusa ćurećeg rinotraheitisa i/ili TRT ili SHS respiratornog poremećaja ordiniranjem in ovo živih, avirulentnih sojeva TRTV, sa odgovarajućim sadržajima doze, računatim po jajetu, za pružanje delotvorne i efikasne vakcinacije koja ima prihvatljivu sigurnost i karakteristike efikasnosti, a pored toga obezbeđuje više titre vakcinisanim pticama nego konvencionale vakcine.[Methods and compositions for protecting avian hosts (e.g., turkeys and/or chickens) from turkey rhinotracheitis virus and/or TRT or SHS respiratory distress in ovo administration of live, avirulent strains of TRTV at appropriate dosage levels on a per egg basis to provide an effective and efficient vaccination having acceptable safety and efficacy features, and additionally provides higher titers in vaccinated birds than conventionally administered vaccines.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25216200P | 2000-11-21 | 2000-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU38503A true YU38503A (sh) | 2006-05-25 |
Family
ID=22954857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU38503A YU38503A (sh) | 2000-11-21 | 2001-11-13 | Postupci i vakcine za pružanje zaštite in ovo protiv ćurećeg rinotraheitisa |
Country Status (25)
Country | Link |
---|---|
US (2) | US20030054016A1 (sh) |
EP (1) | EP1345658B1 (sh) |
JP (1) | JP2004536780A (sh) |
KR (1) | KR20030055314A (sh) |
CN (1) | CN100379452C (sh) |
AR (1) | AR031405A1 (sh) |
AT (1) | ATE361120T1 (sh) |
AU (2) | AU4342602A (sh) |
BG (1) | BG107826A (sh) |
BR (1) | BR0115507A (sh) |
CY (1) | CY1106707T1 (sh) |
CZ (1) | CZ20031419A3 (sh) |
DE (1) | DE60128264T2 (sh) |
DK (1) | DK1345658T3 (sh) |
ES (1) | ES2284717T3 (sh) |
HK (1) | HK1055914A1 (sh) |
HR (1) | HRP20030508A2 (sh) |
HU (1) | HUP0302343A2 (sh) |
MX (1) | MXPA03004432A (sh) |
NZ (1) | NZ526556A (sh) |
PL (1) | PL365848A1 (sh) |
PT (1) | PT1345658E (sh) |
WO (1) | WO2002045745A2 (sh) |
YU (1) | YU38503A (sh) |
ZA (1) | ZA200304762B (sh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115287270B (zh) * | 2022-10-09 | 2023-01-06 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | B亚型禽偏肺病毒传代致弱株及其应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4458630A (en) * | 1982-06-22 | 1984-07-10 | The United States Of America As Represented By The Secretary Of Agriculture | Disease control in avian species by embryonal vaccination |
ES2053732T3 (es) * | 1987-05-21 | 1994-08-01 | Know How Licensors Ltd | Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo. |
EP0431668B1 (en) * | 1989-12-04 | 1995-02-15 | Akzo Nobel N.V. | Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
US6136318A (en) * | 1993-02-26 | 2000-10-24 | Cochran; Mark D. | Recombinant fowlpox viruses and uses thereof |
US5925358A (en) * | 1993-02-26 | 1999-07-20 | Syntro Corporation | Recombinant fowlpox viruses and uses thereof |
CA2156423A1 (en) * | 1993-02-26 | 1994-09-01 | Mark D. Cochran | Recombinant fowlpox viruses and uses thereof |
US6221361B1 (en) * | 1995-01-19 | 2001-04-24 | Syntro Corporation | Recombinant swinepox virus |
FR2750866B1 (fr) * | 1996-06-27 | 1998-11-27 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
FR2751225B1 (fr) * | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique aviaire |
FR2757061B1 (fr) * | 1996-12-16 | 1999-03-26 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
EP0848956A1 (en) | 1996-12-17 | 1998-06-24 | Dimminaco Ag/Sa/Ltd. | In ovo vaccination against Newcastle Disease |
FR2758986B1 (fr) * | 1997-01-31 | 1999-04-30 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
US6506385B1 (en) * | 1998-04-17 | 2003-01-14 | Embrex, Inc. | Live vaccines and methods of treatment therewith |
IL151039A0 (en) | 2000-02-29 | 2003-04-10 | Wyeth Corp | In ovo protection against infectious bronchitis |
-
2001
- 2001-11-09 AR ARP010105251A patent/AR031405A1/es not_active Application Discontinuation
- 2001-11-13 DE DE60128264T patent/DE60128264T2/de not_active Revoked
- 2001-11-13 PT PT01989322T patent/PT1345658E/pt unknown
- 2001-11-13 DK DK01989322T patent/DK1345658T3/da active
- 2001-11-13 ES ES01989322T patent/ES2284717T3/es not_active Expired - Lifetime
- 2001-11-13 KR KR10-2003-7006830A patent/KR20030055314A/ko not_active Application Discontinuation
- 2001-11-13 HU HU0302343A patent/HUP0302343A2/hu unknown
- 2001-11-13 YU YU38503A patent/YU38503A/sh unknown
- 2001-11-13 CN CNB018221092A patent/CN100379452C/zh not_active Expired - Lifetime
- 2001-11-13 NZ NZ526556A patent/NZ526556A/en not_active IP Right Cessation
- 2001-11-13 AU AU4342602A patent/AU4342602A/xx active Pending
- 2001-11-13 MX MXPA03004432A patent/MXPA03004432A/es not_active Application Discontinuation
- 2001-11-13 BR BR0115507-5A patent/BR0115507A/pt not_active IP Right Cessation
- 2001-11-13 JP JP2002547528A patent/JP2004536780A/ja active Pending
- 2001-11-13 WO PCT/US2001/051207 patent/WO2002045745A2/en active IP Right Grant
- 2001-11-13 EP EP01989322A patent/EP1345658B1/en not_active Revoked
- 2001-11-13 US US10/054,288 patent/US20030054016A1/en not_active Abandoned
- 2001-11-13 AT AT01989322T patent/ATE361120T1/de not_active IP Right Cessation
- 2001-11-13 PL PL01365848A patent/PL365848A1/xx not_active Application Discontinuation
- 2001-11-13 AU AU2002243426A patent/AU2002243426B2/en not_active Expired
- 2001-11-13 CZ CZ20031419A patent/CZ20031419A3/cs unknown
-
2003
- 2003-05-19 BG BG107826A patent/BG107826A/bg unknown
- 2003-06-19 ZA ZA2003/04762A patent/ZA200304762B/en unknown
- 2003-06-20 HR HR20030508A patent/HRP20030508A2/hr not_active Application Discontinuation
- 2003-11-14 HK HK03108313A patent/HK1055914A1/xx not_active IP Right Cessation
-
2005
- 2005-10-17 US US11/251,692 patent/US7348012B2/en not_active Expired - Lifetime
-
2007
- 2007-07-05 CY CY20071100897T patent/CY1106707T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE361120T1 (de) | 2007-05-15 |
DE60128264D1 (de) | 2007-06-14 |
PL365848A1 (en) | 2005-01-10 |
US20030054016A1 (en) | 2003-03-20 |
PT1345658E (pt) | 2007-08-09 |
NZ526556A (en) | 2006-06-30 |
WO2002045745A3 (en) | 2002-11-28 |
HRP20030508A2 (en) | 2004-08-31 |
AR031405A1 (es) | 2003-09-24 |
EP1345658A2 (en) | 2003-09-24 |
JP2004536780A (ja) | 2004-12-09 |
DK1345658T3 (da) | 2007-09-17 |
BR0115507A (pt) | 2005-09-20 |
US7348012B2 (en) | 2008-03-25 |
WO2002045745A2 (en) | 2002-06-13 |
HUP0302343A2 (hu) | 2003-10-28 |
EP1345658B1 (en) | 2007-05-02 |
CN1486206A (zh) | 2004-03-31 |
DE60128264T2 (de) | 2008-01-10 |
ZA200304762B (en) | 2005-03-30 |
CY1106707T1 (el) | 2012-05-23 |
MXPA03004432A (es) | 2003-08-19 |
AU4342602A (en) | 2002-06-18 |
AU2002243426B2 (en) | 2007-05-17 |
BG107826A (bg) | 2004-02-27 |
KR20030055314A (ko) | 2003-07-02 |
CZ20031419A3 (cs) | 2004-02-18 |
ES2284717T3 (es) | 2007-11-16 |
US20060034868A1 (en) | 2006-02-16 |
HK1055914A1 (en) | 2004-01-30 |
CN100379452C (zh) | 2008-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Aida et al. | Novel vaccine technologies in veterinary medicine: a herald to human medicine vaccines | |
Calnek et al. | Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease | |
US20150344528A1 (en) | Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens | |
Bosch et al. | Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine | |
YU65102A (sh) | In ovo zaštita protiv infektivnog bronhitisa | |
DK2569007T3 (en) | VACCINE AGAINST Mycoplasma hyopneumoniae SUITABLE FOR ADMINISTRATION IN PRESENCE OF maternally derived antibodies | |
BRPI0407948A (pt) | vacina para uso na proteção de aves domésticas contra a bronquite infecciosa, método para a preparação da mesma, uso de cepa beaudette de ibv, e, método para a proteção de aves domésticas contra a bronquite infecciosa | |
YU38503A (sh) | Postupci i vakcine za pružanje zaštite in ovo protiv ćurećeg rinotraheitisa | |
WO1998026800A1 (en) | In ovo vaccination against newcastle disease | |
WO2004030614A3 (en) | Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor | |
HUT62200A (en) | Cell-free virus vaccine for marek disease | |
JP2655726B2 (ja) | ニューカッスル病ウイルス生ワクチン | |
HU217890B (hu) | Marek-féle betegség vírus elleni vakcina | |
Rahaus et al. | Application of a new bivalent Marek's disease vaccine does not interfere with infectious bronchitis or Newcastle disease vaccinations and proves efficacious | |
TN2014000393A1 (en) | Modified marek's disease virus, and vaccines made therefrom | |
TH62279A (th) | วิธีการและวัคซีนสำหรับการจัดเตรียมการป้องกันในไข่ต่อต้านเทอร์คีไรโนทราคีไอติส | |
JPH07121874B2 (ja) | 感染性気管支炎ワクチン | |
NZ510130A (en) | Chicken anaemia viruses of low pathogenicity | |
US20040146530A1 (en) | Avian vaccine effective against infectious bursal disease virus | |
CA3147040A1 (en) | Method for vaccinating avians against reovirus | |
Paniago et al. | Assessment of the compatibility between the vector RHVT-F and RHVT-H5 vaccines in SPF and commercial chickens | |
Audonnet et al. | Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease | |
Ritchie et al. | Avian polyomavirus vaccine in psittacine birds | |
MaloA et al. | EFFICACY OF VACCINATION PROGRAMS BASED ON A HVT/ND-RECOMBINANT VACCINE AGAINST NEWCASTLE DISEASE AS AN ALTERNATIVE TO CONVENTIONAL PROGRAMS | |
AU2002243426A1 (en) | Methods and vaccines for providing in ovo protection against turkey rhinotracheitis |